Compare CRVO & ORIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRVO | ORIQ |
|---|---|---|
| Founded | 2001 | 2024 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.1M | 87.6M |
| IPO Year | N/A | 2025 |
| Metric | CRVO | ORIQ |
|---|---|---|
| Price | $7.33 | $10.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $21.50 | N/A |
| AVG Volume (30 Days) | ★ 60.7K | 7.5K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,159,786.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.92 | $9.98 |
| 52 Week High | $16.94 | $10.20 |
| Indicator | CRVO | ORIQ |
|---|---|---|
| Relative Strength Index (RSI) | 39.20 | N/A |
| Support Level | $7.61 | N/A |
| Resistance Level | $8.55 | N/A |
| Average True Range (ATR) | 0.59 | 0.00 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 11.71 | 0.00 |
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Origin Investment Corp I is a blank check company.